国际米兰-www.gjmlzww.com|官方中文网

2026-05-18

GUANGZHOU, China --- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline...

查看详情

04-172018

BAT4306F Approved for Phase I Clinical Trials in China

In March 2018, BAT4306F, the recombinant glycosylation-modified anti-human-CD20 monoclonal antibody solution for injecti...
03-302018

Bio-Thera Solutions Announces Two Poster Presentations at the 2018 AACR Annual Meeting

GUANGZHOU, CHINA, March 29, 2018 – Bio-Thera Solutions, a clinical-stage biopharmaceutical company developing a pipeline...
01-052018

Bio-Thera Solutions to Present at the Biotech Showcase 2018 Conference on January 10, 2018

GUANGZHOU, CHINA, January 5, 2018– Bio-Thera Solutions, a clinical-stage biopharmaceutical company developing a pipeline...